In vitro immunization and expansion of antigen-specific cytotoxic T lymphocytes for adoptive immunotherapy using peptide-pulsed dendritic cells

Critical Reviews in Immunology

Volumn 18, Issue 1-2, 1997, Pages 65-75

  Tsai, Van ^a   Kawashima, Ichiro ^b   Keogh, Elissa ^a   Daly, Kieran ^a   Sette, Alessandro ^a   Celis, Esteban ^a  

^a CYTEL CORPORATION   (United States)

^b TAKARA SHUZO CO LTD   (Japan)

Author keywords

CTL; Dendritic cells; MHC binding peptides; Tumor antigens

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 7; PEPTIDE;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; CANCER IMMUNOTHERAPY; CELL CULTURE; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TUMOR REJECTION; ADOPTIVE TRANSFER; ARTICLE; CYTOLOGY; IMMUNIZATION; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY;

ADOPTIVE TRANSFER; DENDRITIC CELLS; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030721439     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Nabholz, M. and MacDonald, H. R., Cytolytic T lymphocytes, Annu. Rev. Immunol., 1, 273-305, 1983.
2. Rammensee, H. G., Falk, K., and Rotzschke, O., MHC molecules as peptide receptors, Curr. Opin. Immunol., 5(1), 35-44, 1993.
3. Cells, E.,Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., and Serra, H. M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes, Proc. Natl. Acad. Sci. U.S.A., 91(6), 2105-2109, 1994.
4. van der Bruggen, P., Bastin, J., Gajewski,T.,Coulie, P. G., Boel, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3, Eur. J. Immunol., 24(12), 3038-3043, 1994.
5. Wentworth, P. A., Celis, E., Crimi, C., Stkely, S., Hale, L., Tsai V., Serra, H. M., del Guercio, M. F., Livingston, B., Alazard, D., Fikes, J., Kubo, R. T., Grey, H. M., Chesnut, R. W., Chisari, F. V., and Sette, A., In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides, Mol. Immunol., 32(9), 603-612, 1995.
6. Alderson, M. R., Tough, T. W., Ziegler, S. F., and Grabstein, K. H., Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes, J. Exp. Med., 173(4), 923-930, 1991.
7. Kos, F. J. and Müllbacher, A., Induction of primary antiviral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7, Eur. J. Immunol., 22, 3183-3185, 1992.
8. Chen, W.-F. and Zlotnik, A., IL-10: a novel cytotoxic T cell differentiation factor, J. Immunol., 147, 528-534, 1991.
9. Yang, G., Hellstrom, K. E., Mizuno, M. T., and Chen, L., In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation, J. Immunol., 155(8), 3897-3903, 1995.
10. Ferrari, G., King, K., Rathbun, K., Place, C. A., Packard, M. V., Bartlett, J. A., Bolognesi, D. P., and Weinhold, K. J., IL-7 enhancement of antigendriven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp), Clin. Exp. Immunol., 101(2), 239-248, 1995.
11. Bertoletti, A., Chisari, F. V., Penna, A., Guilhot, S., Galati, L., Missale, G., Fowler, P., Schlicht, H. J., Vitiello, A., Chesnut, R. C., et al., Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein, J. Virol., 67(4), 2376-2380, 1993.
12. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethe, B., Brasseur, F., and Boon, T., Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes, J. Exp. Med., 179(3), 921-930, 1994.
13. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines, Science, 264(5159), 716-719, 1994.
14. Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., and Rosenberg, S. A., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating lymphocytes associated with in vivo tumor regression, J. Immunol., 154, 3961-3968, 1995.
15. Tsai, V., Firestein, G. S., Arend, W., and Zvaifler, N. J., Cytokine-induced differentiation of cultured non-adherent macrophages, Cell. Immunol., 144, 203-216, 1992.
16. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacker, B., Konwalkinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G., Proliferating dendritic cell progenitors in human blood, J. Exp. Med., 180, 83-93, 1994.
17. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α, J. Exp. Med., 179(4), 1109-1118, 1994.
18. Tsai, V., Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., and Celis, E., Identification of subdominant CTL epitopes of the gp100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells, J. Immunol., 158, 1796-1802, 1997.
19. Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., and Greenberg, P. D., T-cell mediated rejection of genemodified HIV-specific cytotoxic T lymphocytes in HIV-infected patients, Nature Med., 2, 216-223, 1996.
20. Clark, S. C. and Kamen, R., The human hematopoietic colony-stimulating factors, Science, 236, 1229-1237,1987.
21. Gagliardi, M. C., Petrillo, G. D., Salemi, S., Boffa, L., Longobardi, M. G., Dellabona, P., Casorati, G., Tanigaki, N., Harris, R., Lanzavecchia, A., and Barnaba, V., Presentation of peptides by cultured monocytes or activated T cells allows specific prim- ing of human cytotoxic T lymphocytes in vitro, Int. Immunol., 7(11), 1741-1752, 1995.
22. Plebanski, M., Allsopp, C. E., Aidoo, M., Reyburn, H., and Hill, A. V., Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood, Eur. J. Immunol., 25, 1783-1787, 1994.
23. Houbiers, J. G., Nijman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J., Brand, A., Momburg, F., Kast, W. M., and Melief, C. J., In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53, Eur. J. Immunol., 23(9), 2072-2077, 1993.
24. Young, J. W. and Steinman, R. M., Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells, J. Exp. Med., 171, 1315-1332, 1990.
25. Mehta-Damani, A., Merkowicz, S., and Engleman, E. G., Generation of antigen-specific CD8+ CTLs from naive precursors, J. Immunol., 153, 996-1003, 1994.
26. Bakker, A. B. H., Marland, G., Boer, A. J. D., Huijbens, R. J. F., Danen, E. H. J., Adema, G. J., and Figdor, C. G., Generation of antimelanoma cy- totoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro., Cancer Res., 55, 5330-5334, 1995.
27. Steinman, R. M., The dendritic cell system and its role in immunogenicity, Annu. Rev. Immunol., 9, 271-296, 1991.
28. van Elsas, A., van der Burg, S. H., van der Minne, C. E., Borghi, M., Mourer, J. S., Melief, C. J. M., and Schrier, P. I., Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201 -binding peptides from the Melan-A/MART-1 self antigen, Eur. J. Immunol., 26, 1683-1689, 1996.
29. Mayordomo, J. I., Zorina, T., Storkus, W. J., Celluzzi, C., Falo, L., Kast, W. M., IIdstad, S. T., DeLeo, A. B., and Lotze, M. T., Bone marrow-derived dendritic cells pulsed with tumor peptides elicit protective and therapeutic anti-tumor immunity, Nature Med., 1, 1297-1303, 1995.
30. Mayordomo, J. I., Loftus, D. J., Sakamoto, H., Cesare, C. M. D., Appasamy, P. M., Lotze, M. T., Storkus, W. J., Appella, E., and DeLeo, A. B., Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines, J. Exp. Med., 183, 1357-1365, 1996.
31. Moore, K. W., Garra, A. O., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R., Interleukin-10, Annu. Rev. Immunol., 11, 165-190, 1993.
32. de Vries, J. E., Immunosuppressive and antiinflammatory properties of interleukin 10, Ann Med., 27(5), 537-541, 1995.
33. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., and Billah, M. M., IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells, J. Immunol, 153, 811-816, 1994.
34. Alleva, D. G., Burger, C. J., and Elgert, K. D., Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2, J. Immunol, 153(4), 1674-1686, 1994.
35. Berkman, N., John, M., Roesems, G., Jose, P. J., Barnes, P. J., and Chung, K. F., Inhibition of macrophage inflammatory protein-1 expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages, J. Immunol., 155, 4412-4418, 1995.
36. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., and Dayer, J. M., IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes, J. Clin, Invest., 96, 2304-2310, 1995.
37. Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G., and Wahl, L. M., Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production, J. Biol. Chem., 269(33), 21322-21329, 1994.
38. Armstrong, L., Jordan, N., and Millar, A., Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes, Thorax, 51(2), 143-149, 1996.
39. Niiro, H., Otsuka, T., Kuga, S., Nemoto, Y., Abe, M., Hara, N., Nakano, T., Ogo, T., and Niho, Y., IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes, Int. Immunol., 6(4), 661-664, 1994.